Dianthus Therapeutics | MGTA - Kapitał Akcyjny

Cena Akcji
61.55
Dzienna Zmiana
6.16 11.12%
Miesięcznie
32.14%
Rocznie
170.43%
Q1 Prognozy TE
53.50




Kapitał Akcyjny Zmiana Data
Akebia Therapeutics USD 2K 0 2025-03
Alaunos Therapeutics USD 2.21M 2.2M 2025-09
Celltrion KRW 218.78M 1.5M 2025-09
Cspc Pharmaceutical CNY 11.52B 486M 2025-06
Deva Holding AS TRY 200.02M 0 2023-09
Dianthus Therapeutics USD 42.85M 42.82M 2025-09
Divis Laboratories Ltd INR 265.47M 264.53M 2025-09
IQVIA Holdings USD 169.6M 700K 2025-12
Kangmei Pharma CNY 13.86B 0 2025-06
Knight Therapeutics CAD 539.32M 1.63M 2024-09
Laboratorios Farma EUR 51.82M 1.55M 2023-12
Malin Corporation EUR 200K 0 2024-12
Medical Developments International AUD 112.66M 2.35M 2025-12
Moderna USD 391M 2M 2025-09
Neuren Pharmaceuticals AUD 126.64M 38.63M 2025-12
Organigram Holdings CAD 134.46M 438.86K 2025-09
Organon & Co USD 259.98M 18K 2025-09
Ovoca Bio EUR 11.06M 0 2022-06
Pharma Mar EUR 17.36M 214.99K 2025-12
Qiagen NV USD 216.56M 284.67K 2025-12
Revvity USD 113.38M 2.7M 2025-12
Sartorius EUR 69.04M 0 2025-09
Sino Biopharmaceutical CNY 17.89B 30.5M 2025-06
Tectonic Therapeutic USD 14.86M 111.83K 2024-12
Tilray USD 1.06B 86.93M 2025-03
Viatris USD 1.16B 6.55M 2025-09
Xeris Pharmaceuticals USD 165.53M 165.51M 2025-09
Zz Pientze Pharmaceu CNY 603.32M 0 2025-09